- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Philips rearranges field organization
Philips Medical Systems North America of Shelton, CT, plans to restructure its field sales organization, the company announced last month. The firm will create four operating units that will be located in New York, Los Angeles, Chicago, and Atlanta. The
Philips Medical Systems North America of Shelton, CT, plans to restructure its field sales organization, the company announced last month. The firm will create four operating units that will be located in New York, Los Angeles, Chicago, and Atlanta. The four-unit structure will replace the company's previous two-zone sales configuration. Each regional operating unit will function under a regional vice president, and the regional bases' activities will be coordinated with headquarters vice presidents, according to the company. Philips plans to increase its North American sales force by 20%.
The company is making the change to accommodate a more diverse client base, according to Jack Price, president and CEO. Philips hopes the new structure will allow it to respond more quickly and with more flexibility to its customers, which include independent hospitals, national and regional affiliations, HMOs, buying groups, and freestanding imaging centers.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
